Back to search
FDAFDA · Food and drugs·Recall number D-1290-2020

Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.

Published June 17, 2020 · Recall initiated: May 28, 2020

Summary

FDA records drug Class II recall D-1290-2020, published June 17, 2020 and initiated May 28, 2020. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 4,224 bottles; Lot: Lot # Q900683, Exp. 10/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

What to do

Voluntary: Firm initiated · Letter

Get an email if LISINOPRIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LISINOPRIL
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide within the US.
UPC
0368180513018
Lot
Lot # Q900683, Exp. 10/31/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03. recalled?

Yes. FDA published recall D-1290-2020 on June 17, 2020. Reported hazard: Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LISINOPRIL. UPC: 0368180513018.